首页 > 最新文献

Boletín médico del Hospital Infantil de México最新文献

英文 中文
Comprehensive safety assessment of diode laser circumcision in children: a retrospective cohort study. 儿童二极管激光包皮环切术的综合安全性评价:回顾性队列研究。
IF 0.7 Q4 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.24875/BMHIM.25000104
Rodrigo Tapia-Borgo, Lucía L Cuevas-López, Diana E Villa-Guillén

Background: Pediatric circumcision is a common procedure, with reported acute complication rates of 0.5-10%. This study evaluated the safety of diode laser circumcision in pediatric patients treated at a private hospital in Culiacán, Sinaloa, Mexico (2022-2023).

Methods: Retrospective cohort of 51 patients ≤ 17 years who underwent diode laser circumcision diagnosed with phimosis (n = 29), balanitis (n = 13), balanitis xerotica obliterans (n = 5), and paraphimosis (n = 4). General anesthesia was used in patients under 10 years, and local block with sedation in older patients. Acute complications, operative time, and reinterventions were recorded. Operative time was compared by diagnosis using the Kruskal-Wallis test, and age was correlated with procedure duration using Spearman's correlation. Follow-up was performed at postoperative days 7 and 30.

Results: No significant bleeding, wound dehiscence, or reinterventions were observed. Median operative time was 15 minutes across all groups, with similar means among diagnoses. No correlation was found between age and procedure duration (r: -0.08; p = 0.593) and no significant differences were observed among diagnoses (p = 0.183).

Conclusions: Diode laser pediatric circumcision showed a favorable safety profile and homogeneous operative times. The limited sample size restricts generalizability, requiring prospective multicenter studies to confirm these findings.

背景:儿科包皮环切术是一种常见的手术,据报道急性并发症发生率为0.5-10%。本研究评估了2022-2023年在墨西哥锡那罗亚Culiacán一家私立医院治疗的儿科患者的二极管激光包皮环切术的安全性。方法:回顾性队列研究51例年龄≤17岁的患者,他们接受了二极管激光包皮环切术,诊断为包茎病(n = 29)、balanitis (n = 13)、balanitis xerotica obliterans (n = 5)和parapigosis (n = 4)。10岁以下患者全麻,老年患者局部阻滞加镇静。记录急性并发症、手术时间和再干预情况。采用Kruskal-Wallis检验比较手术时间,采用Spearman相关分析年龄与手术时间的相关性。术后第7天和第30天进行随访。结果:无明显出血、创面裂开或再干预。所有组的中位手术时间为15分钟,诊断的平均值相似。年龄与手术时间无相关性(r: -0.08; p = 0.593),诊断间无显著差异(p = 0.183)。结论:二极管激光小儿包皮环切术具有良好的安全性和均匀的手术时间。有限的样本量限制了普遍性,需要前瞻性的多中心研究来证实这些发现。
{"title":"Comprehensive safety assessment of diode laser circumcision in children: a retrospective cohort study.","authors":"Rodrigo Tapia-Borgo, Lucía L Cuevas-López, Diana E Villa-Guillén","doi":"10.24875/BMHIM.25000104","DOIUrl":"https://doi.org/10.24875/BMHIM.25000104","url":null,"abstract":"<p><strong>Background: </strong>Pediatric circumcision is a common procedure, with reported acute complication rates of 0.5-10%. This study evaluated the safety of diode laser circumcision in pediatric patients treated at a private hospital in Culiacán, Sinaloa, Mexico (2022-2023).</p><p><strong>Methods: </strong>Retrospective cohort of 51 patients ≤ 17 years who underwent diode laser circumcision diagnosed with phimosis (n = 29), balanitis (n = 13), balanitis xerotica obliterans (n = 5), and paraphimosis (n = 4). General anesthesia was used in patients under 10 years, and local block with sedation in older patients. Acute complications, operative time, and reinterventions were recorded. Operative time was compared by diagnosis using the Kruskal-Wallis test, and age was correlated with procedure duration using Spearman's correlation. Follow-up was performed at postoperative days 7 and 30.</p><p><strong>Results: </strong>No significant bleeding, wound dehiscence, or reinterventions were observed. Median operative time was 15 minutes across all groups, with similar means among diagnoses. No correlation was found between age and procedure duration (r: -0.08; p = 0.593) and no significant differences were observed among diagnoses (p = 0.183).</p><p><strong>Conclusions: </strong>Diode laser pediatric circumcision showed a favorable safety profile and homogeneous operative times. The limited sample size restricts generalizability, requiring prospective multicenter studies to confirm these findings.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"83 3","pages":"195-201"},"PeriodicalIF":0.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148547814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complementary feeding in Mexico by 2026: a review and recommendations from the Academia Mexicana de Pediatría. 墨西哥到2026年的补充喂养:墨西哥科学院Pediatría的审查和建议。
IF 0.7 Q4 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.24875/BMHIM.M26000047
Rodrigo Vázquez-Frias, Mara Medeiros-Domingo, Horacio Márquez-González, Magali Reyes-Apodaca, Norma C Ayuzo-Del Valle, Alejandro Barrón-Balderas, Roberto G Calva-Rodríguez, Magdalena Cerón-Rodríguez, Roberto Cervantes-Bustamante, Pedro Coello-Ramírez, José A García-Aranda, Sara Guillen-López, Vanessa Hernández-Rosiles, Alfredo Larrosa-Haro, Lizbeth López-Mejía, José A Madrazo-de la Garza, Reynaldo de J Michel-Aceves, Ericka Montijo-Barrios, Erika Ochoa-Ortiz, Carlos I Oyervides-García, Salvador Villalpando-Carrión, Gerardo R Zaragoza-Arévalo, Flora E Zárate-Mondragón

The present document aims to present a reflection derived from a narrative review on the evolution of complementary feeding (CF) recommendations worldwide and their application in Mexico. Based on the analysis of international guidelines and consensus statements, such as those published by European Society for Pediatric Gastroenterology, Hepatology and Nutrition, Latin American Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the World Health Organization, members of the Mexican Academy of Pediatrics review the main points of convergence and controversy related to the initiation, progression, and characteristics of CF during the first two years of life. The document highlights that this period is critical for growth, neurological development, immune maturation, and the establishment of healthy eating habits in the long term. Likewise, it emphasizes the relevance of the first 1000 days of life and the need to promote breastfeeding, dietary diversity, and the timely introduction of foods rich in essential nutrients. The review also addresses current topics such as the early introduction of allergenic foods, the role of different food textures, the prevention of obesity and allergies, as well as the importance of avoiding sugar-sweetened beverages, ultra-processed foods, and restrictive diets without specialized supervision. From the Mexican perspective, it is recognized that international recommendations must be contextualized according to the epidemiological, cultural, and social realities of the country. Finally, the Academia Mexicana de Pediatría proposes practical recommendations directed at healthcare professionals to promote responsive, safe, and evidence-based CF that contributes to the overall well-being of Mexican infants.

本文件旨在对世界范围内辅食喂养建议的演变及其在墨西哥的应用进行叙述性回顾,并提出反思。基于对国际指南和共识声明的分析,例如欧洲儿科胃肠病学、肝病学和营养学会、拉丁美洲儿科胃肠病学、肝病学和营养学会以及世界卫生组织发表的指南和共识声明,墨西哥儿科学会的成员回顾了与CF的发生、进展和生命最初两年的特征相关的主要趋同点和争议点。该文件强调,这一时期对于生长、神经发育、免疫成熟和长期健康饮食习惯的建立至关重要。同样,它强调了生命最初1000天的重要性,以及促进母乳喂养、饮食多样性和及时摄入富含必需营养素的食物的必要性。该综述还讨论了当前的主题,如早期引入致敏食物,不同食物质地的作用,预防肥胖和过敏,以及在没有专门监督的情况下避免含糖饮料、超加工食品和限制性饮食的重要性。从墨西哥的角度来看,人们认识到,国际建议必须根据该国的流行病学、文化和社会现实情况加以考虑。最后,墨西哥学术界Pediatría提出了针对医疗保健专业人员的实用建议,以促进响应性、安全性和基于证据的CF,从而有助于墨西哥婴儿的整体福祉。
{"title":"Complementary feeding in Mexico by 2026: a review and recommendations from the Academia Mexicana de Pediatría.","authors":"Rodrigo Vázquez-Frias, Mara Medeiros-Domingo, Horacio Márquez-González, Magali Reyes-Apodaca, Norma C Ayuzo-Del Valle, Alejandro Barrón-Balderas, Roberto G Calva-Rodríguez, Magdalena Cerón-Rodríguez, Roberto Cervantes-Bustamante, Pedro Coello-Ramírez, José A García-Aranda, Sara Guillen-López, Vanessa Hernández-Rosiles, Alfredo Larrosa-Haro, Lizbeth López-Mejía, José A Madrazo-de la Garza, Reynaldo de J Michel-Aceves, Ericka Montijo-Barrios, Erika Ochoa-Ortiz, Carlos I Oyervides-García, Salvador Villalpando-Carrión, Gerardo R Zaragoza-Arévalo, Flora E Zárate-Mondragón","doi":"10.24875/BMHIM.M26000047","DOIUrl":"https://doi.org/10.24875/BMHIM.M26000047","url":null,"abstract":"<p><p>The present document aims to present a reflection derived from a narrative review on the evolution of complementary feeding (CF) recommendations worldwide and their application in Mexico. Based on the analysis of international guidelines and consensus statements, such as those published by European Society for Pediatric Gastroenterology, Hepatology and Nutrition, Latin American Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the World Health Organization, members of the Mexican Academy of Pediatrics review the main points of convergence and controversy related to the initiation, progression, and characteristics of CF during the first two years of life. The document highlights that this period is critical for growth, neurological development, immune maturation, and the establishment of healthy eating habits in the long term. Likewise, it emphasizes the relevance of the first 1000 days of life and the need to promote breastfeeding, dietary diversity, and the timely introduction of foods rich in essential nutrients. The review also addresses current topics such as the early introduction of allergenic foods, the role of different food textures, the prevention of obesity and allergies, as well as the importance of avoiding sugar-sweetened beverages, ultra-processed foods, and restrictive diets without specialized supervision. From the Mexican perspective, it is recognized that international recommendations must be contextualized according to the epidemiological, cultural, and social realities of the country. Finally, the Academia Mexicana de Pediatría proposes practical recommendations directed at healthcare professionals to promote responsive, safe, and evidence-based CF that contributes to the overall well-being of Mexican infants.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"83 3","pages":"141-150"},"PeriodicalIF":0.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148547883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of the "Golden Hour" program in preventing sepsis in pediatric patients with acute lymphoblastic leukemia. “黄金时间”计划预防小儿急性淋巴细胞白血病患者脓毒症的有效性。
IF 0.7 Q4 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.24875/BMHIM.25000135
Mónica V Cárdenas-Monsibaiz, Enrique Villarreal-Ríos, Karla E Margain-Pérez, Liliana Galicia-Rodríguez, Jesús González-Aparicio
<p><strong>Introducción: </strong>La iniciativa «Hora Dorada» se propone para reducir complicaciones graves en pacientes oncológicos pediátricos con neutropenia febril. Se refiere a la administración de antibiótico de amplio espectro en la primera hora de la atención en el servicio de urgencias. Los pacientes con leucemia linfoblástica aguda son de alto riesgo por la inmunosupresión prolongada. El objetivo fue determinar la administración de antibiótico dentro de los primeros 60 minutos como factor asociado a menor incidencia de sepsis en pacientes con leucemia linfoblástica aguda.</p><p><strong>Métodos: </strong>Diseño de cohorte retrospectiva en expedientes de pacientes pediátricos con diagnóstico de leucemia linfoblástica aguda. Los grupos se integraron en función del tiempo de administración del antibiótico posterior al ingreso a triaje. En el grupo con administración oportuna (≤ 60 minutos) se estudiaron 44 pacientes y en el grupo con atención tardía (> 60 minutos), 11 pacientes. El diagnóstico de sepsis utilizó de referencia los criterios de Phoenix. El tiempo triaje-administración de antibiótico se midió en minutos. El análisis estadístico incluyó regresión logística simple y cálculo de probabilidad de ocurrencia del evento.</p><p><strong>Resultados: </strong>El 54.5% del grupo con atención tardía desarrolló sepsis, en el grupo con atención oportuna la incidencia fue del 22.7% (p = 0.038). El modelo de regresión logística reportó significancia (p = 0.004). La probabilidad de desarrollar sepsis fue del 49.1% a los 80 minutos, el 35.5% a los 60 minutos y el 56% a los 90 minutos.</p><p><strong>Conclusiones: </strong>La administración de antibiótico dentro de los primeros 60 minutos se asoció con menor incidencia de sepsis en pacientes con leucemia linfoblástica aguda.</p><p><strong>Background: </strong>The “Golden Hour” initiative is intended to reduce serious complications in pediatric oncology patients with febrile neutropenia, and it refers to the administration of broad-spectrum antibiotics within the first hour of care in the emergency department. Patients with acute lymphoblastic leukemia are at high risk due to prolonged immunosuppression. The objective was to determine the administration of antibiotics within the first 60 minutes as a factor associated with a lower incidence of sepsis in patients with acute lymphoblastic leukemia.</p><p><strong>Methods: </strong>Retrospective cohort design in the records of pediatric patients diagnosed with acute lymphoblastic leukemia, with groups organized based on the time of antibiotic administration after triage admission. In the timely administration group (≤ 60 minutes), 44 patients were studied, and in the delayed care group (> 60 minutes), 11 patients. The diagnosis of sepsis used the Phoenix criteria as a reference. The time between triage and antibiotic administration was measured in minutes. The statistical analysis included simple logistic regression and calculation of the probability of
简介:“黄金时间”倡议旨在减少发热性中性粒细胞减少症儿科肿瘤患者的严重并发症。它指的是在急诊科治疗的最初几个小时内给予广谱抗生素。急性淋巴母细胞白血病患者由于长期免疫抑制而处于高风险。目的是确定在急性淋巴母细胞白血病患者中,在最初60分钟内给予抗生素是否与较低的败血症发病率相关。方法:对诊断为急性淋巴母细胞白血病的儿科患者档案进行回顾性队列设计。根据分诊后给药抗生素的时间分组。及时给药组(≤60分钟)44例,晚给药组(> 60分钟)11例。败血症的诊断采用凤凰标准作为基线。三联服用抗生素的时间以分钟为单位。统计分析包括简单的逻辑回归和事件发生概率的计算。结果:晚期护理组54.5%发生败血症,及时护理组22.7% (p = 0.038)。逻辑回归模型报告了显著性(p = 0.004)。80分钟时罹患败血症的机率为49.1%,60分钟时为35.5%,90分钟时为56%。结论:在急性淋巴母细胞白血病患者中,60分钟内给予抗生素与较低的败血症发病率相关。背景:“黄金时间”倡议旨在减少发热性中性粒细胞减少症儿科肿瘤学患者的严重并发症,它指的是在急诊科护理的第一个小时内使用广谱抗生素。急性淋巴细胞白血病患者由于免疫抑制时间延长而处于高风险。目的是确定在最初60分钟内使用抗生素作为与急性淋巴细胞白血病患者败血症发病率降低相关的因素。方法:对诊断为急性淋巴母细胞白血病的儿科患者记录进行回顾性队列设计,根据分诊入院后抗生素给药时间分组。在及时给药组(≤60分钟)中,研究了44例患者,在延迟护理组(> 60分钟)中,研究了11例患者。败血症的诊断以凤凰标准为参考。分诊和抗生素给药之间的时间以分钟为单位。统计分析包括简单的逻辑回归和事件发生概率的计算。结果:晚期护理组54%发生败血症,而晚期护理组22.7%发生败血症(p = 0.038)。物流回归模型报告了显著性(p = 0.004)。80分钟时患败血症的几率为49.1%,60分钟时为35.5%,90分钟时为56%。结论:在急性淋巴细胞白血病患者中,前60分钟内给予抗生素与降低败血症发病率相关。
{"title":"Effectiveness of the \"Golden Hour\" program in preventing sepsis in pediatric patients with acute lymphoblastic leukemia.","authors":"Mónica V Cárdenas-Monsibaiz, Enrique Villarreal-Ríos, Karla E Margain-Pérez, Liliana Galicia-Rodríguez, Jesús González-Aparicio","doi":"10.24875/BMHIM.25000135","DOIUrl":"https://doi.org/10.24875/BMHIM.25000135","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introducción: &lt;/strong&gt;La iniciativa «Hora Dorada» se propone para reducir complicaciones graves en pacientes oncológicos pediátricos con neutropenia febril. Se refiere a la administración de antibiótico de amplio espectro en la primera hora de la atención en el servicio de urgencias. Los pacientes con leucemia linfoblástica aguda son de alto riesgo por la inmunosupresión prolongada. El objetivo fue determinar la administración de antibiótico dentro de los primeros 60 minutos como factor asociado a menor incidencia de sepsis en pacientes con leucemia linfoblástica aguda.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Métodos: &lt;/strong&gt;Diseño de cohorte retrospectiva en expedientes de pacientes pediátricos con diagnóstico de leucemia linfoblástica aguda. Los grupos se integraron en función del tiempo de administración del antibiótico posterior al ingreso a triaje. En el grupo con administración oportuna (≤ 60 minutos) se estudiaron 44 pacientes y en el grupo con atención tardía (&gt; 60 minutos), 11 pacientes. El diagnóstico de sepsis utilizó de referencia los criterios de Phoenix. El tiempo triaje-administración de antibiótico se midió en minutos. El análisis estadístico incluyó regresión logística simple y cálculo de probabilidad de ocurrencia del evento.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Resultados: &lt;/strong&gt;El 54.5% del grupo con atención tardía desarrolló sepsis, en el grupo con atención oportuna la incidencia fue del 22.7% (p = 0.038). El modelo de regresión logística reportó significancia (p = 0.004). La probabilidad de desarrollar sepsis fue del 49.1% a los 80 minutos, el 35.5% a los 60 minutos y el 56% a los 90 minutos.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusiones: &lt;/strong&gt;La administración de antibiótico dentro de los primeros 60 minutos se asoció con menor incidencia de sepsis en pacientes con leucemia linfoblástica aguda.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The “Golden Hour” initiative is intended to reduce serious complications in pediatric oncology patients with febrile neutropenia, and it refers to the administration of broad-spectrum antibiotics within the first hour of care in the emergency department. Patients with acute lymphoblastic leukemia are at high risk due to prolonged immunosuppression. The objective was to determine the administration of antibiotics within the first 60 minutes as a factor associated with a lower incidence of sepsis in patients with acute lymphoblastic leukemia.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Retrospective cohort design in the records of pediatric patients diagnosed with acute lymphoblastic leukemia, with groups organized based on the time of antibiotic administration after triage admission. In the timely administration group (≤ 60 minutes), 44 patients were studied, and in the delayed care group (&gt; 60 minutes), 11 patients. The diagnosis of sepsis used the Phoenix criteria as a reference. The time between triage and antibiotic administration was measured in minutes. The statistical analysis included simple logistic regression and calculation of the probability of ","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"83 4","pages":"274-278"},"PeriodicalIF":0.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148812037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pityriasis lichenoides chronica in a Mexican pediatric series: clinical-epidemiological profile and therapeutic approach. 墨西哥儿科系列慢性地衣样糠疹:临床流行病学概况和治疗方法。
IF 0.7 Q4 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.24875/BMHIM.25000146
Juan A Godínez-Chaparro, Helena Vidaurri-de la Cruz, Ixchel R Ramírez-Ricarte, Óscar G Aguirre-Félix

Background: Pityriasis lichenoides chronica (PLC) is a rare dermatosis in children, with limited epidemiological data restricting its clinical and therapeutic characterization.

Methods: A retrospective case series was conducted at two tertiary care hospitals in Mexico City. Electronic records of patients younger than 18 years of both sexes with a diagnosis of PLC confirmed by histopathology were included in the study. The study period was from January 2017 to March 2025.

Results: Thirty-five confirmed cases were analysed (51.4% female and 48.6% male). The mean time to diagnosis was 2.4 years after lesion onset. The median disease duration was 24 months (interquartile ranges 9-49), with recurrence in 67.5% of cases. The most common sites were the trunk and extremities (65.7%), with predominance of erythematous-squamous papules and plaques (48.6%) that, upon resolution, left hypopigmented macules in 80% of patients. Phototherapy was used in 25.7% and oral methotrexate (MTX) in 22.9% of cases. In patients with prolonged disease duration (> 36 months), higher recurrence rates, longer MTX use, and, in some cases, greater use of phototherapy were observed.

Conclusions: Pediatric PLC in a Mexican case series showed a chronic and recurrent course, with a low rate of resolution. The high frequency of recurrences and therapeutic variability, including MTX and phototherapy in prolonged cases, highlights the need for standardized treatment protocols.

背景:慢性地衣样糠疹(PLC)是一种罕见的儿童皮肤病,流行病学资料有限,限制了其临床和治疗特点。方法:在墨西哥城的两家三级医院进行回顾性病例系列研究。年龄小于18岁且经组织病理学证实为PLC的患者的电子记录也被纳入研究。研究时间为2017年1月至2025年3月。结果:共确诊35例,其中女性51.4%,男性48.6%。平均诊断时间为发病后2.4年。中位病程为24个月(四分位数范围9-49),67.5%的病例复发。最常见的部位是躯干和四肢(65.7%),主要是红斑鳞状丘疹和斑块(48.6%),在80%的患者中,消退后留下低色素斑。光疗占25.7%,口服甲氨蝶呤(MTX)占22.9%。在病程延长的患者中(60 - 36个月),观察到更高的复发率,更长时间的MTX使用,并且在某些情况下,更多地使用光疗。结论:在一个墨西哥病例系列中,小儿PLC表现为慢性和复发病程,治愈率低。复发的高频率和治疗的可变性,包括MTX和长期病例的光疗,突出了标准化治疗方案的必要性。
{"title":"Pityriasis lichenoides chronica in a Mexican pediatric series: clinical-epidemiological profile and therapeutic approach.","authors":"Juan A Godínez-Chaparro, Helena Vidaurri-de la Cruz, Ixchel R Ramírez-Ricarte, Óscar G Aguirre-Félix","doi":"10.24875/BMHIM.25000146","DOIUrl":"10.24875/BMHIM.25000146","url":null,"abstract":"<p><strong>Background: </strong>Pityriasis lichenoides chronica (PLC) is a rare dermatosis in children, with limited epidemiological data restricting its clinical and therapeutic characterization.</p><p><strong>Methods: </strong>A retrospective case series was conducted at two tertiary care hospitals in Mexico City. Electronic records of patients younger than 18 years of both sexes with a diagnosis of PLC confirmed by histopathology were included in the study. The study period was from January 2017 to March 2025.</p><p><strong>Results: </strong>Thirty-five confirmed cases were analysed (51.4% female and 48.6% male). The mean time to diagnosis was 2.4 years after lesion onset. The median disease duration was 24 months (interquartile ranges 9-49), with recurrence in 67.5% of cases. The most common sites were the trunk and extremities (65.7%), with predominance of erythematous-squamous papules and plaques (48.6%) that, upon resolution, left hypopigmented macules in 80% of patients. Phototherapy was used in 25.7% and oral methotrexate (MTX) in 22.9% of cases. In patients with prolonged disease duration (> 36 months), higher recurrence rates, longer MTX use, and, in some cases, greater use of phototherapy were observed.</p><p><strong>Conclusions: </strong>Pediatric PLC in a Mexican case series showed a chronic and recurrent course, with a low rate of resolution. The high frequency of recurrences and therapeutic variability, including MTX and phototherapy in prolonged cases, highlights the need for standardized treatment protocols.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"83 4","pages":"279-286"},"PeriodicalIF":0.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148812003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Septic shock secondary to disseminated coccidioidomycosis: case report. 播散性球孢子菌病继发感染性休克1例。
IF 0.7 Q4 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.24875/BMHIM.25000069
Gerardo F Ramos, M A Elisa Vásquez-Sandoval, Rodrigo García-Pérez

Introducción: La coccidioidomicosis es una infección endémica en el norte de México causada por Coccidioides immitis y Coccidioides posadasii. Su principal manifestación es en los pulmones, aunque cerca del 1% puede tener afectación de otros órganos, lo que se conoce como coccidioidomicosis diseminada. De forma infrecuente, estos casos pueden cursar con choque séptico. En pediatría, esta forma de expresión está infraestudiada, pero se ha asociado con elevada mortalidad.

Caso clínico: Se presenta el caso de una paciente de 16 años que acudió por una lesión ulcerativa en región cervical acompañado de fiebre y pérdida de peso de 2 meses de evolución. Durante su estancia desarrolló choque séptico refractario aunado a endocarditis y tuvo fallo multiorgánico con un desenlace fatal.

Conclusiones: Debe considerarse esta micosis como causa de choque séptico en zonas endémicas donde no existe una causa específica.

Background: Coccidioidomycosis is an endemic infection in northern Mexico caused by Coccidioides immitis and Coccidioides posadasii. Its main manifestation is in the lungs, although approximately 1% may affect other organs, which is known as disseminated coccidioidomycosis. Rarely, these cases can present with septic shock. In pediatrics, this form of expression is understudied but has been associated with high mortality.

Clinical case: We describe the case of a 16-year-old female who presented with an ulcerative lesion in the cervical region accompanied by fever and weight loss that had lasted 2 months. During her stay, she developed refractory septic shock combined with endocarditis and suffered multiorgan failure with a fatal outcome.

Conclusions: This mycosis should be considered as a cause of septic shock in endemic areas where there is no specific etiology.

球虫病是墨西哥北部由immitis球虫和posadasii球虫引起的一种地方性感染。它的主要表现在肺部,尽管大约1%的人可能受到其他器官的影响,这被称为弥漫性球虫病。在极少数情况下,这些病例可能导致脓毒症休克。在儿科,这种表达形式的研究不足,但它与高死亡率有关。临床病例:一名16岁的女性患者,因颈部溃疡而来,并伴有2个月的发烧和体重下降。在住院期间,他出现了难治性脓毒症休克和心内膜炎,并出现了多器官衰竭,最终导致了致命的后果。结论:在没有特定病因的流行地区,应将这种真菌病视为化粪池休克的病因。背景:球孢子虫病是墨西哥北部由伊米特球孢子虫和波萨达西球孢子虫引起的一种地方性感染。它的主要表现在肺部,尽管大约1%的人可能会影响其他器官,这被称为弥漫性球虫病。这些病例很少会出现脓毒症休克。在儿童中,这种表达形式仍在研究中,但已与高死亡率有关。临床病例:我们描述了一名16岁女性的病例,她的颈部有溃疡损伤,并伴有发烧和体重下降,持续了2个月。在她逗留期间,她患上了难治性脓毒症休克和心内膜炎,并遭受了多器官衰竭,造成了致命的后果。结论:在没有特定病因的流行地区,这种真菌病应被认为是脓毒症休克的一个原因。
{"title":"Septic shock secondary to disseminated coccidioidomycosis: case report.","authors":"Gerardo F Ramos, M A Elisa Vásquez-Sandoval, Rodrigo García-Pérez","doi":"10.24875/BMHIM.25000069","DOIUrl":"https://doi.org/10.24875/BMHIM.25000069","url":null,"abstract":"<p><strong>Introducción: </strong>La coccidioidomicosis es una infección endémica en el norte de México causada por Coccidioides immitis y Coccidioides posadasii. Su principal manifestación es en los pulmones, aunque cerca del 1% puede tener afectación de otros órganos, lo que se conoce como coccidioidomicosis diseminada. De forma infrecuente, estos casos pueden cursar con choque séptico. En pediatría, esta forma de expresión está infraestudiada, pero se ha asociado con elevada mortalidad.</p><p><strong>Caso clínico: </strong>Se presenta el caso de una paciente de 16 años que acudió por una lesión ulcerativa en región cervical acompañado de fiebre y pérdida de peso de 2 meses de evolución. Durante su estancia desarrolló choque séptico refractario aunado a endocarditis y tuvo fallo multiorgánico con un desenlace fatal.</p><p><strong>Conclusiones: </strong>Debe considerarse esta micosis como causa de choque séptico en zonas endémicas donde no existe una causa específica.</p><p><strong>Background: </strong>Coccidioidomycosis is an endemic infection in northern Mexico caused by Coccidioides immitis and Coccidioides posadasii. Its main manifestation is in the lungs, although approximately 1% may affect other organs, which is known as disseminated coccidioidomycosis. Rarely, these cases can present with septic shock. In pediatrics, this form of expression is understudied but has been associated with high mortality.</p><p><strong>Clinical case: </strong>We describe the case of a 16-year-old female who presented with an ulcerative lesion in the cervical region accompanied by fever and weight loss that had lasted 2 months. During her stay, she developed refractory septic shock combined with endocarditis and suffered multiorgan failure with a fatal outcome.</p><p><strong>Conclusions: </strong>This mycosis should be considered as a cause of septic shock in endemic areas where there is no specific etiology.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"83 4","pages":"296-300"},"PeriodicalIF":0.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148811980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mexican version of the Autism Behavior Checklist: validity and reliability. 墨西哥版自闭症行为检查表:效度与信度。
IF 0.7 Q4 PEDIATRICS Pub Date : 2026-01-01 DOI: 10.24875/BMHIM.25000059
Lilia Albores-Gallo, Karen L Varela-Orozco, Ofelia Roldán-Ceballos, Claudia List-Hilton, Ana P Maurer

Background: The Autism Behavior Checklist (ABC) evaluates symptoms in individuals with Autism Spectrum Disorders (ASD) within a school setting. The purpose of this study was to evaluate the validity of the ABC Mexican version.

Methods: Participants were children (n = 133, aged 2-17). All parents were interviewed with the autism diagnostic interview-revised (ADI-R) to confirm an ASD diagnosis and then answered the ABC checklist. The sample for the ABC test-retest analysis consisted of 19 parents with unaffected typically developing children between 2 and 17 years old.

Results: Children and adolescents (n = 133) with a mean age of 6.9 years (standard deviation [SD] 3.7), 83.5% were males. The ABC total mean score was 69.3 (SD 25). The Internal consistency through the Cronbach Alfa coefficient was α = 0.83 < p = 0.001 for the 57 ABC items. The 10-day test-retest reliability showed a Pearson correlation coefficient of r = 0.98, p < 0.001. The Spearman correlation coefficients between the ABC subscales and the ADI-R ranged from (rs = 0.494) to (rs = 0.816). Criterion validity with a cutoff of 30 resulted in a sensitivity of 87% and a specificity of 37%. The best Kappa coefficient was 0.285 between the ABC and the ADI-R.

Conclusions: The Mexican ABC has good psychometric properties. Further studies should investigate its value in educational settings.

背景:自闭症行为检查表(ABC)在学校环境中评估自闭症谱系障碍(ASD)个体的症状。本研究的目的是评估ABC墨西哥版的效度。方法:参与者为儿童(n = 133,年龄2-17岁)。所有家长都接受了自闭症诊断访谈-修订版(ADI-R)的访谈,以确认ASD的诊断,然后回答ABC清单。ABC测试-再测试分析的样本包括19对父母,他们的孩子年龄在2到17岁之间,发育正常,未受影响。结果:儿童和青少年(n = 133),平均年龄6.9岁(标准差[SD] 3.7),男性占83.5%。ABC总平均评分为69.3分(SD 25)。57个ABC条目的Cronbach alpha系数的内部一致性为α = 0.83 < p = 0.001。10天重测信度Pearson相关系数r = 0.98, p < 0.001。ABC子量表与ADI-R的Spearman相关系数为(rs = 0.494) ~ (rs = 0.816)。标准效度截止值为30,敏感性为87%,特异性为37%。ABC与ADI-R的最佳Kappa系数为0.285。结论:墨西哥ABC具有良好的心理测量特性。进一步的研究应探讨其在教育环境中的价值。
{"title":"Mexican version of the Autism Behavior Checklist: validity and reliability.","authors":"Lilia Albores-Gallo, Karen L Varela-Orozco, Ofelia Roldán-Ceballos, Claudia List-Hilton, Ana P Maurer","doi":"10.24875/BMHIM.25000059","DOIUrl":"https://doi.org/10.24875/BMHIM.25000059","url":null,"abstract":"<p><strong>Background: </strong>The Autism Behavior Checklist (ABC) evaluates symptoms in individuals with Autism Spectrum Disorders (ASD) within a school setting. The purpose of this study was to evaluate the validity of the ABC Mexican version.</p><p><strong>Methods: </strong>Participants were children (n = 133, aged 2-17). All parents were interviewed with the autism diagnostic interview-revised (ADI-R) to confirm an ASD diagnosis and then answered the ABC checklist. The sample for the ABC test-retest analysis consisted of 19 parents with unaffected typically developing children between 2 and 17 years old.</p><p><strong>Results: </strong>Children and adolescents (n = 133) with a mean age of 6.9 years (standard deviation [SD] 3.7), 83.5% were males. The ABC total mean score was 69.3 (SD 25). The Internal consistency through the Cronbach Alfa coefficient was α = 0.83 < p = 0.001 for the 57 ABC items. The 10-day test-retest reliability showed a Pearson correlation coefficient of r = 0.98, p < 0.001. The Spearman correlation coefficients between the ABC subscales and the ADI-R ranged from (rs = 0.494) to (rs = 0.816). Criterion validity with a cutoff of 30 resulted in a sensitivity of 87% and a specificity of 37%. The best Kappa coefficient was 0.285 between the ABC and the ADI-R.</p><p><strong>Conclusions: </strong>The Mexican ABC has good psychometric properties. Further studies should investigate its value in educational settings.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"83 4","pages":"252-260"},"PeriodicalIF":0.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148812026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Exploring Langerhans cell histiocytosis in childhood: case series]. 探讨儿童朗格汉斯细胞组织细胞增多症:病例系列。
IF 0.7 Q4 PEDIATRICS Pub Date : 2025-11-18 DOI: 10.24875/BMHIM.24000134
Irvin Ordoñez-González, Yail I Chirinos-Chirinos, Edoardo Figueroa-Pimentel, Ritha A Vázquez-Díaz, Laura L Franco-Mejía, Pedro Valencia-Mayoral, Carlos A Serrano-Bello, Juan R Murillo-Eliosa

Background: Langerhans cell histiocytosis (LCH) is a rare, multisystem hematologic disease characterized by the clonal proliferation of mononuclear phagocytes in various tissues and organs. In Mexico, its incidence in children is 4.3 cases per million. The disease presents a clinical variety that can mimic other medical conditions, making diagnosis challenging. Pediatricians play a crucial role in the early identification of adenopathy, which can be indicative of LCH or other pathologies.

Clinical cases: Case 1. A 6-month-old infant with cervical adenopathy, fever, anemia and cutaneous compromise; biopsy with immunohistochemistry confirmed the disease. Case 2. A 2-year-old boy with retroauricular adenopathy, exophthalmos, and pallor. Lytic bone lesions and lymph node biopsy confirmed the disease, classified as group I. Case 3. A 1-year-old boy with generalized dermatosis, progressive adenopathies, and symptoms of diabetes insipidus; studies confirmed LCH and vasopressin deficiency.

Conclusions: LCH is currently classified into groups based on the extent of the disease. The presented cases reflect different clinical forms, underscoring the importance of early detection and accurate diagnosis to improve prognosis. Delayed diagnosis can lead to less effective treatments and additional complications. The clinical variability of LCH poses a diagnostic challenge in pediatrics. This analysis emphasizes the importance of early diagnosis and appropriate treatment to improve prognosis. It is essential for pediatricians to consider other causes of adenopathy before considering an oncological diagnosis and to conduct a thorough evaluation for timely referral to subspecialists.

背景:朗格汉斯细胞组织细胞增多症(LCH)是一种罕见的多系统血液病,其特征是单个核吞噬细胞在各组织和器官中克隆性增殖。在墨西哥,儿童发病率为每百万人4.3例。这种疾病表现出临床多样性,可以模仿其他医疗条件,使诊断具有挑战性。儿科医生在早期识别腺病方面起着至关重要的作用,腺病可以指示LCH或其他病理。临床病例:病例1。6个月大的婴儿出现宫颈腺病、发热、贫血和皮肤损伤;免疫组织化学活检证实该疾病。例2。2岁男童耳后腺病,眼球突出,面色苍白。溶解性骨病变及淋巴结活检证实该疾病,分类为i组。1岁男童,有全身性皮肤病、进行性腺病和尿崩症症状;研究证实LCH和抗利尿激素缺乏。结论:LCH目前根据疾病的严重程度进行分组。这些病例反映了不同的临床形式,强调早期发现和准确诊断对改善预后的重要性。延迟诊断可能导致治疗效果降低和其他并发症。LCH的临床变异性对儿科的诊断提出了挑战。这一分析强调了早期诊断和适当治疗对改善预后的重要性。对于儿科医生来说,在考虑肿瘤诊断之前,考虑其他原因的腺病是至关重要的,并进行彻底的评估,以便及时转诊给专科医生。
{"title":"[Exploring Langerhans cell histiocytosis in childhood: case series].","authors":"Irvin Ordoñez-González, Yail I Chirinos-Chirinos, Edoardo Figueroa-Pimentel, Ritha A Vázquez-Díaz, Laura L Franco-Mejía, Pedro Valencia-Mayoral, Carlos A Serrano-Bello, Juan R Murillo-Eliosa","doi":"10.24875/BMHIM.24000134","DOIUrl":"10.24875/BMHIM.24000134","url":null,"abstract":"<p><strong>Background: </strong>Langerhans cell histiocytosis (LCH) is a rare, multisystem hematologic disease characterized by the clonal proliferation of mononuclear phagocytes in various tissues and organs. In Mexico, its incidence in children is 4.3 cases per million. The disease presents a clinical variety that can mimic other medical conditions, making diagnosis challenging. Pediatricians play a crucial role in the early identification of adenopathy, which can be indicative of LCH or other pathologies.</p><p><strong>Clinical cases: </strong>Case 1. A 6-month-old infant with cervical adenopathy, fever, anemia and cutaneous compromise; biopsy with immunohistochemistry confirmed the disease. Case 2. A 2-year-old boy with retroauricular adenopathy, exophthalmos, and pallor. Lytic bone lesions and lymph node biopsy confirmed the disease, classified as group I. Case 3. A 1-year-old boy with generalized dermatosis, progressive adenopathies, and symptoms of diabetes insipidus; studies confirmed LCH and vasopressin deficiency.</p><p><strong>Conclusions: </strong>LCH is currently classified into groups based on the extent of the disease. The presented cases reflect different clinical forms, underscoring the importance of early detection and accurate diagnosis to improve prognosis. Delayed diagnosis can lead to less effective treatments and additional complications. The clinical variability of LCH poses a diagnostic challenge in pediatrics. This analysis emphasizes the importance of early diagnosis and appropriate treatment to improve prognosis. It is essential for pediatricians to consider other causes of adenopathy before considering an oncological diagnosis and to conduct a thorough evaluation for timely referral to subspecialists.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":" ","pages":"202-208"},"PeriodicalIF":0.7,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145547911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Generalized pustular psoriasis: a rare entity in pediatrics]. [全身性脓疱性牛皮癣:儿科罕见的疾病]。
IF 0.7 Q4 PEDIATRICS Pub Date : 2025-11-04 DOI: 10.24875/BMHIM.24000140
Citlalli F Pérez-López, Miriam Dávila-Patiño, Adriana M Valencia-Herrera, Mirna E Toledo-Bahena, Carlos A Mena-Cedillos, Sonia Toussaint-Caire, Ma Elisa Vega-Memije

Background: Generalized pustular psoriasis is a rare and severe systemic inflammatory disease characterized by skin erythema and visible sterile pustules. Associated with hereditary and external factors, it can be life-threatening and requires specialized diagnosis and treatment.

Clinical case: A 6-year-old male with disseminated dermatosis of 7 months evolution, initially appearing in the retroauricular region with erythematous scaly plaques and pustular lesions, spreading to various body segments, accompanied by intense pruritus, fever, and tachycardia. Histopathological examination reported psoriasiform dermatitis with lymphocytes, plasma cell aggregates, and neutrophils forming microabscesses in the stratum corneum, compatible with a diagnosis of pustular psoriasis. Treatment included methotrexate at 12 mg/m²/week, folic acid, 1% methylprednisolone aceponate cream, 0.005% calcipotriol, urea-based emollient at 10%, and antihistamines.

Conclusions: Generalized pustular psoriasis in pediatrics requires comprehensive care, considering not only dermatological aspects but also psychosocial factors. Successful management of pediatric cases, as described, highlights the importance of a personalized approach tailored to each patient's needs to achieve long-term satisfactory outcomes.

背景:全身性脓疱性银屑病是一种罕见且严重的全身性炎症性疾病,以皮肤红斑和可见的无菌脓疱为特征。它与遗传和外部因素有关,可能危及生命,需要专门的诊断和治疗。临床病例:6岁男性,弥散性皮肤病,发展7个月,最初出现于耳后区域,伴有红斑鳞状斑块和脓疱性病变,向身体各节段扩散,伴强烈瘙痒,发热,心动过速。组织病理学检查报告银屑病样皮炎伴淋巴细胞、浆细胞聚集体和中性粒细胞在角质层形成微脓肿,符合脓疱性银屑病的诊断。治疗包括甲氨蝶呤(12 mg/m²/周)、叶酸、1%乙酰甲泼尼龙乳膏、0.005%钙化三醇、10%脲基润肤剂和抗组胺药。结论:小儿广泛性脓疱性银屑病需要综合护理,不仅要考虑皮肤病学方面的因素,还要考虑心理社会因素。成功的管理儿科病例,如所述,强调个性化的方法量身定制的每个病人的需要,以实现长期满意的结果的重要性。
{"title":"[Generalized pustular psoriasis: a rare entity in pediatrics].","authors":"Citlalli F Pérez-López, Miriam Dávila-Patiño, Adriana M Valencia-Herrera, Mirna E Toledo-Bahena, Carlos A Mena-Cedillos, Sonia Toussaint-Caire, Ma Elisa Vega-Memije","doi":"10.24875/BMHIM.24000140","DOIUrl":"10.24875/BMHIM.24000140","url":null,"abstract":"<p><strong>Background: </strong>Generalized pustular psoriasis is a rare and severe systemic inflammatory disease characterized by skin erythema and visible sterile pustules. Associated with hereditary and external factors, it can be life-threatening and requires specialized diagnosis and treatment.</p><p><strong>Clinical case: </strong>A 6-year-old male with disseminated dermatosis of 7 months evolution, initially appearing in the retroauricular region with erythematous scaly plaques and pustular lesions, spreading to various body segments, accompanied by intense pruritus, fever, and tachycardia. Histopathological examination reported psoriasiform dermatitis with lymphocytes, plasma cell aggregates, and neutrophils forming microabscesses in the stratum corneum, compatible with a diagnosis of pustular psoriasis. Treatment included methotrexate at 12 mg/m²/week, folic acid, 1% methylprednisolone aceponate cream, 0.005% calcipotriol, urea-based emollient at 10%, and antihistamines.</p><p><strong>Conclusions: </strong>Generalized pustular psoriasis in pediatrics requires comprehensive care, considering not only dermatological aspects but also psychosocial factors. Successful management of pediatric cases, as described, highlights the importance of a personalized approach tailored to each patient's needs to achieve long-term satisfactory outcomes.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":" ","pages":"209-213"},"PeriodicalIF":0.7,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145443963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[MIA 2.0, Comprehensive asthma management, guidelines for Mexico]. [MIA 2.0,综合哮喘管理,墨西哥指南]。
IF 0.7 Q4 PEDIATRICS Pub Date : 2025-05-06 DOI: 10.24875/BMHIM.M25000042
Désirée E S Larenas-Linnemann, Jorge A Luna-Pech, Arturo Cortés-Telles, Elsy M Navarrete-Rodríguez, Blanca E Del Río-Navarro, Ricardo Lemus-Rangel, Rodrigo F Del Río-Hidalgo, Ulises N García-Ramírez, Mario Soto-Ramos, Federico I Hernández-Rocha, Eulogio Muñoz-Miranda, Iván Zamarrón-Reyes, Catalina Casillas-Suárez, Irlanda Alvarado-Amador, Marcos A Jiménez-Chobillón, Abril D Alemán-Ortega, Roberto Camargo-Ángeles, Armando Campos-Rivera, José L Carrillo-Alduenda, Víctor M Carrillo-Rodríguez, Francisco J Cuevas-Schacht, Roberto Dávalos-Valenzuela, Karina Díaz-Jiménez, Ma de Lourdes Rodríguez-Aguilera, Elizabeth Estrada-Reyes, Yair H González-Tuyub, Emilia M Hidalgo-Castro, Carlos Juárez-Ortíz, Ma de la Luz López-Vázquez, Adriana Del C Luna-Castañeda, Nora E Martínez-Aguilar, Anabell D Méndez-García, Carol V Moncayo-Coello, Ernesto Onuma-Takane, Jorge Vazquez-García, Ma Mayela Villarreal-de la Rosa, Benjamín Zepeda-Ortega, Andrés Sánchez-González, Luis C Hinojos-Gallardo, Adela Reyes-Herrera

Background: In 2020, a multidisciplinary group developed Integrated Asthma Management (MIA), guidelines for asthma in Mexico, based on international asthma guidelines. Since then, several concepts and treatments have been updated.

Objective: To create a current version of MIA, strongly based on evidence, and to add the management of severe asthma exacerbations.

Methodology: MIA 2.0 uses the ADAPTE method. The MIA 2.0 guideline development group consists of a core group (experts in pulmonology-allergology-methodology) and representatives of 16 institutions/societies of specialties that manage asthma. The international reference guidelines (selected with AGREE-II) were: GINA 2024, GEMA 5.4, BTS/SIGN 2024 and Australian Asthma Handbook 2021. MIA 2.0 covers diagnosis, treatment, severe asthma, exacerbations and special groups. Key clinical questions were formulated for I) diagnosis, II) treatment steps 1-4, III) severe asthma and IV) exacerbations.

Results: Based on evidence in reference guidelines, safety, cost and local reality, the core group developed responses to the clinical questions. Through a Delphi process, the MIA 2.0 development group suggested adjustments until consensus was reached.

Conclusion: A document was generated with multiple figures and algorithms, about asthma management including exacerbations treatment, adjusted for Mexico broadly based among different societies that participated in its development.

背景:2020年,一个多学科小组根据国际哮喘指南制定了墨西哥哮喘综合管理(MIA)指南。从那时起,一些概念和治疗方法得到了更新。目的:创建一个基于证据的当前版本的MIA,并增加对严重哮喘发作的管理。方法:MIA 2.0使用ADAPTE方法。MIA 2.0指南制定小组由一个核心小组(肺病学-过敏学-方法学专家)和16个哮喘管理专业机构/学会的代表组成。国际参考指南(与AGREE-II一起选择)是:GINA 2024、GEMA 5.4、BTS/SIGN 2024和Australian Asthma Handbook 2021。MIA 2.0涵盖诊断、治疗、严重哮喘、恶化和特殊群体。制定了以下关键临床问题:1)诊断,2)治疗步骤1-4,3)严重哮喘和4)急性发作。结果:根据参考指南的证据、安全性、成本和当地的实际情况,核心小组对临床问题做出了回应。通过德尔菲过程,MIA 2.0开发小组提出了调整建议,直到达成共识。结论:生成了一份包含多种数据和算法的文件,涉及哮喘管理,包括急性加重治疗,并根据参与其发展的不同社会广泛调整墨西哥。
{"title":"[MIA 2.0, Comprehensive asthma management, guidelines for Mexico].","authors":"Désirée E S Larenas-Linnemann, Jorge A Luna-Pech, Arturo Cortés-Telles, Elsy M Navarrete-Rodríguez, Blanca E Del Río-Navarro, Ricardo Lemus-Rangel, Rodrigo F Del Río-Hidalgo, Ulises N García-Ramírez, Mario Soto-Ramos, Federico I Hernández-Rocha, Eulogio Muñoz-Miranda, Iván Zamarrón-Reyes, Catalina Casillas-Suárez, Irlanda Alvarado-Amador, Marcos A Jiménez-Chobillón, Abril D Alemán-Ortega, Roberto Camargo-Ángeles, Armando Campos-Rivera, José L Carrillo-Alduenda, Víctor M Carrillo-Rodríguez, Francisco J Cuevas-Schacht, Roberto Dávalos-Valenzuela, Karina Díaz-Jiménez, Ma de Lourdes Rodríguez-Aguilera, Elizabeth Estrada-Reyes, Yair H González-Tuyub, Emilia M Hidalgo-Castro, Carlos Juárez-Ortíz, Ma de la Luz López-Vázquez, Adriana Del C Luna-Castañeda, Nora E Martínez-Aguilar, Anabell D Méndez-García, Carol V Moncayo-Coello, Ernesto Onuma-Takane, Jorge Vazquez-García, Ma Mayela Villarreal-de la Rosa, Benjamín Zepeda-Ortega, Andrés Sánchez-González, Luis C Hinojos-Gallardo, Adela Reyes-Herrera","doi":"10.24875/BMHIM.M25000042","DOIUrl":"10.24875/BMHIM.M25000042","url":null,"abstract":"<p><strong>Background: </strong>In 2020, a multidisciplinary group developed Integrated Asthma Management (MIA), guidelines for asthma in Mexico, based on international asthma guidelines. Since then, several concepts and treatments have been updated.</p><p><strong>Objective: </strong>To create a current version of MIA, strongly based on evidence, and to add the management of severe asthma exacerbations.</p><p><strong>Methodology: </strong>MIA 2.0 uses the ADAPTE method. The MIA 2.0 guideline development group consists of a core group (experts in pulmonology-allergology-methodology) and representatives of 16 institutions/societies of specialties that manage asthma. The international reference guidelines (selected with AGREE-II) were: GINA 2024, GEMA 5.4, BTS/SIGN 2024 and Australian Asthma Handbook 2021. MIA 2.0 covers diagnosis, treatment, severe asthma, exacerbations and special groups. Key clinical questions were formulated for I) diagnosis, II) treatment steps 1-4, III) severe asthma and IV) exacerbations.</p><p><strong>Results: </strong>Based on evidence in reference guidelines, safety, cost and local reality, the core group developed responses to the clinical questions. Through a Delphi process, the MIA 2.0 development group suggested adjustments until consensus was reached.</p><p><strong>Conclusion: </strong>A document was generated with multiple figures and algorithms, about asthma management including exacerbations treatment, adjusted for Mexico broadly based among different societies that participated in its development.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"82 Supl 2","pages":"1-150"},"PeriodicalIF":0.7,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144149228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial steps in the selection of a child development screening instrument in the peruvian context. 在秘鲁选择儿童发展筛查工具的初始步骤。
IF 0.6 Q4 PEDIATRICS Pub Date : 2025-01-01 DOI: 10.24875/BMHIM.24000156
Carla P Cortez-Vergara, Gisely Hijar-Guerra, Blanca Távara-Campos, María E Ugaz-Villacorta

Background: The foundational elements for optimal well-being and health are established during the early stages of life. When progress does not meet expectations, it is necessary to explore possible disorders, health conditions, or other probable factors affecting it. Health professionals in our country must have access to developmental screening instruments that facilitate early detection of these potential risks and delays, thus enabling timely intervention.

Methods: After a pre-selection of the evidence and adequate training of a multi-sectoral panel, a virtual deliberative dialog was held with key stakeholders and decision-makers to determine the most appropriate development screening instrument for the Peruvian context. The evidence was analyzed and discussed in light of the established criteria. In addition, factors pertaining to implementation on a national level were discussed.

Results: A set of instruments were obtained and prioritized in the following order: Evaluation of Child Development (EDI, Spanish acronym) ranked first, followed by the Abbreviated Developmental Scale Third Edition (EAD-3, Spanish acronym) and the Ages and Stages Questionnaire (ASQ-3, Spanish acronym), based on the established criteria. The primary components implicated in the execution of this evaluation on a national scale were subsequently identified.

Conclusions: This deliberative dialog has enabled a first approach to the selection of a development screening instrument on the national level, providing valuable information to guide the implementation process.

背景:最佳福祉和健康的基本要素是在生命的早期阶段建立起来的。当进展不符合预期时,有必要探索可能的疾病、健康状况或其他可能的影响因素。我国的保健专业人员必须有机会使用发育筛查工具,以便及早发现这些潜在风险和延误,从而能够及时进行干预。方法:在对证据进行预选并对多部门小组进行充分培训后,与主要利益攸关方和决策者进行了虚拟审议对话,以确定最适合秘鲁情况的发展筛选工具。根据既定标准对证据进行了分析和讨论。此外,还讨论了与国家一级执行有关的因素。结果:获得了一套工具,并按以下顺序排序:儿童发展评价量表(EDI,西班牙语首字母缩写)排名第一,其次是简易发展量表第三版(EAD-3,西班牙语首字母缩写)和年龄与阶段问卷(ASQ-3,西班牙语首字母缩写)。随后确定了在国家范围内执行这项评价所涉及的主要组成部分。结论:这一审议性对话使在国家一级选择发展筛选工具成为可能,为指导执行进程提供了宝贵的信息。
{"title":"Initial steps in the selection of a child development screening instrument in the peruvian context.","authors":"Carla P Cortez-Vergara, Gisely Hijar-Guerra, Blanca Távara-Campos, María E Ugaz-Villacorta","doi":"10.24875/BMHIM.24000156","DOIUrl":"10.24875/BMHIM.24000156","url":null,"abstract":"<p><strong>Background: </strong>The foundational elements for optimal well-being and health are established during the early stages of life. When progress does not meet expectations, it is necessary to explore possible disorders, health conditions, or other probable factors affecting it. Health professionals in our country must have access to developmental screening instruments that facilitate early detection of these potential risks and delays, thus enabling timely intervention.</p><p><strong>Methods: </strong>After a pre-selection of the evidence and adequate training of a multi-sectoral panel, a virtual deliberative dialog was held with key stakeholders and decision-makers to determine the most appropriate development screening instrument for the Peruvian context. The evidence was analyzed and discussed in light of the established criteria. In addition, factors pertaining to implementation on a national level were discussed.</p><p><strong>Results: </strong>A set of instruments were obtained and prioritized in the following order: Evaluation of Child Development (EDI, Spanish acronym) ranked first, followed by the Abbreviated Developmental Scale Third Edition (EAD-3, Spanish acronym) and the Ages and Stages Questionnaire (ASQ-3, Spanish acronym), based on the established criteria. The primary components implicated in the execution of this evaluation on a national scale were subsequently identified.</p><p><strong>Conclusions: </strong>This deliberative dialog has enabled a first approach to the selection of a development screening instrument on the national level, providing valuable information to guide the implementation process.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"82 Supl 1","pages":"25-35"},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143633532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Boletín médico del Hospital Infantil de México
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1